PharmaKure’s Novel Blood Test Successfully Identifies Biomarkers in Alzheimer’s Patients
PharmaKure announced successful study results for a novel whole-blood test for quantifying Alzheimer’s Disease biomarkers.
Read MorePosted by Andy Lundin | Oct 17, 2023 | Dementias & Alzheimer’s |
PharmaKure announced successful study results for a novel whole-blood test for quantifying Alzheimer’s Disease biomarkers.
Read MorePosted by Chris Wolski | Oct 13, 2023 | Breast |
Invitae announced the results of its study on universal hereditary cancer genetic testing in breast cancer patients in a rural population.
Read MorePosted by Andy Lundin | Oct 10, 2023 | Sequencing Systems |
Centogene announced the expansion of MOx, the company’s multiomic diagnostic portfolio, now incorporating transcriptomic analysis.
Read MorePosted by Andy Lundin | Oct 5, 2023 | Cancer |
The FDA granted de novo marketing authorization for a test that can help detect genetic variants associated with a predisposition to cancers.
Read MorePosted by Chris Wolski | Oct 4, 2023 | Colorectal |
The ColoAlert test is designed as a complement to colonoscopies and is designed to help detect colorectal cancer early.
Read More